Amgen Alters Anemia Drug Discounts
Monday, September 1, 2008 - 09:07
in Health & Medicine
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.